Endurance Wealth Management, Inc. Vbi Vaccines Inc Transaction History

Endurance Wealth Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 15, 2021	BUY	$2.15 - $3.5 $5,912 - $9,625	2,750 Added 30.56%	11,750 $27,000
Q3 2020 Oct 27, 2020	BUY	$2.77 - $6.17 $24,896 - $55,455	8,988 Added 74900.0%	9,000 $25,000
Q2 2020 Jul 14, 2020	BUY	$0.87 - $3.13 $4 - $15	5 Added 71.43%	12 $38,000
Q4 2019 Jan 14, 2020	BUY	$0.48 - $1.38 $3 - $9	7 New	7 $10,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Endurance Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Endurance Wealth Management, Inc. with notifications on news.